Merida Capital Archives - Page 2 of 2 - Green Market Report

Debra BorchardtJune 14, 2019
IMG_4385-1280x960.jpg

4min4140

A forum called “Insights From The Front Lines Of The Cannabis Industry” was held on June 13 on a beautiful summer evening in New York City atop the Empire Hotel. New York was named the Empire state because it was considered to be the center of all business in America and it has become the center of cannabis investing even though the plant isn’t fully legal in the state. That could change soon.

The event was hosted by MGO, Ello, Wilson Elser, and Aon. The panelists included Kevin Murphy Chairman and CEO, Acreage Holdings (CSE: ACRG.U), Tiffany Liff Managing Director, Cresco Capital Partners, Evan Eneman CEO, MGO / ELLO Cannabis Alliance, Matt Markiewicz Managing Director, Innovation Shares, Eduardo Provencio General Counsel, Mary’s Brands, and Mitch Baruchowitz Managing Partner, Merida Capital.

New York’s legalization was discussed as Murphy said it is quickly changing. “Last week, I’d have said there was a 20% chance. Today I give it a 60/40 chance. I think on Wednesday it may happen,” he said. That sure sent a buzz through the crowd. He conceded that having former Speaker of the House John Boehner on the company’s board kept his company informed of political maneuverings. Murphy has also been actively working on the SAFE Banking Act. As a company with its roots in New York, he is keen to see changes at the state level.

Access To Capital

A key theme seemed to emerge among some of the panelists was the access to capital. “The industry has gone from basement growers who just wanted to have a bigger basement to getting a license. Now it is about the aggregation of licenses,” said Murphy. “Our biggest competition isn’t from each other but from the black market.”

Liff also noted that in the early days’ companies were forced to go public even if they weren’t really ready because there was no other way to access capital. “There are more options now,” she said. She also reiterated that she really focuses on backing the management team.

“Running a public company is not that awesome,” said Murphy. “There is an extra layer or two of accountability. Having said that, it gives us the opportunity to access capital.”

Baruchowitz pointed out that new companies often give themselves rich valuations based on angel investors and believe this should bring them more capital. “When your angel round is friends and family, that doesn’t justify certain valuations. They get shocked when they get asked the hard questions as they ask for more capital. A lot of the newcomers don’t know the grind.”

Illegal vs. Legal

Baruchowitz noted that since New York didn’t have the same ballot pressures that other states have, legalization could come easier. Having said that, the panelists noted that the quasi-illegal status has had some benefits. Baruchowitz said he believes the medicalization of cannabis is about to go on hyperdrive through legalization.

The illegality of cannabis has also caused some volatility in the cannabis company stocks. Markiewicz runs an ETF and noted that the volatility scares many advisors. He keeps an eye out for negative sentiment when reviewing his companies. The illegal nature attracts some less than savory players at times. Still, Murphy said that ETF’s provide liquidity for the stocks. “The more liquidity, the better for all of us,” he said.


William SumnerApril 4, 2019
daily_hit004-1280x533.png

4min2160

It’s time for your Daily Hit of cannabis financial news for April 4, 2019.

On the Site

Merida Capital

Cannabis private equity fund Merida Capital Partners has launched its third fund for $200 million, which will focus on concentrated, high conviction investments in leading companies in the cannabis ecosystem. The company said that since launching its first fund in late 2016, it has deployed nearly $80 million across its first two funds and now has more than $125MM under management.

McConnell & Wyden Pen Letters To US Federal Banking Finance Regulators Over Financial Services For Hemp Producers

The letters were sent to the U.S. Federal Deposit Insurance Corporation (FDIC), the Farm Credit Administration, the Federal Reserve System and the Office of the Comptroller of the Currency. The letters read as follows.

Marijuana Stocks Look Frothy, But Aurora Stock Is Well-Prepared

Over the long run, I remain net bullish on legal marijuana. However, my optimism for the sector doesn’t cloud reality. I can see as plain as daylight that the honeymoon phase is over. Now, companies like Aurora Cannabis (NYSE: ACB) must provide the goods. If not, ACB stock could face serious trouble.

In Other News

Harvest Health & Recreation

Harvest Health & Recreation, Inc. (CSE: HARV) announced that it has entered into a brokered private sale of up to 500,000 convertible debentures of the company, at a price of $1,000 per debenture. The sale is expected to raise $500 million and will be closed in five tranches over a period of no more than 18 months. The first tranche is expected to close on May 1, 2019. Proceeds from the sale will go towards general corporate purposes and working capital.

Halo Labs

The cannabis extraction company Halo Labs Inc. (OTC: AGEEF) announced that it has raised $18,143,000 in a convertible note offering. The proceeds of the offering will go towards leasehold improvements, the purchase of extraction equipment, working capital and general corporate purposes.

Aurora Cannabis

Aurora Cannabis Inc. (NYSE: ACB) announced that it has appointed Carey Squires as its Executive Vice President of Corporate Development and Strategy. Squires recently served as Managing Director and Co-Head of Equity-Linked Capital Markets for BMO Capital Markets. In his new role, Squires will focus on developing strategic partnerships, growth initiatives, and investor development.


StaffApril 4, 2019
money4-2.jpg

9min2640

Cannabis private equity fund Merida Capital Partners has launched its third fund for $200 million, which will focus on concentrated, high conviction investments in leading companies in the cannabis ecosystem. The company said that since launching its first fund in late 2016, it has deployed nearly $80 million across its first two funds and now has more than $125MM under management.

The company counts a portfolio of 25 investments through public listings for GrowGeneration, Vireo Health, and CB2 Insights as well as leading investments in public companies KushCo Holdings and Freedom Leaf Health.

“As Merida transitions to our third fund, we continue to define our thesis through the depth of our information gathering and synthesis, our focus on ecosystem connectivity, portfolio company governance and identifying opportunities that offer asymmetric upside returns to our investors,” said Mitch Baruchowitz, Merida Capital Partners Managing Partner. “Through the knowledge gained from investments made in Funds I and II, our incredible team of investment professionals will continue to implement our strategy of risk-mitigated investments in leading companies throughout the cannabis industry.”

In addition to announcing the new fund, Merida said it was also expanding its international operations by opening an office in Toronto, Canada to go with its New York flagship office and satellite offices in San Francisco and Bethesda, Maryland.

“Having met the Merida team shortly after the launch of Fund I, I have been able to watch Merida thoughtfully navigate the challenges of the cannabis industry as both an investor and a member of Merida’s Investment Committee,” said Danny Moses, Merida Capital Partners Investment Committee Member. “The amount of research and diligence performed on both potential and current investments, including deal structure and corporate governance, is where Merida truly excels. I am excited to continue my work on the Investment Committee with the rapidly growing team as they launch Fund III.”

In addition, the firm announced the expansion of its team with three new key hires, which brings the firm’s total employee count to 19.

Dr. Deb Kimless, Chief Scientific Officer

Dr. Deb Kimless, an expert on cannabinoid research and cannabis-based medicines, has joined Merida as its Chief Scientific Officer, overseeing Merida’s research efforts as well as identifying opportunities in the life sciences and biotechnology verticals. Dr. Kimless is a board-certified anesthesiologist with a subspecialty in pain management and holds a B.S. in Natural Sciences and Biology from Muhlenberg College and an MD from Rutgers University.

Matthew Bartlett, West Coast Operating Partner

Matthew Bartlett recently joined Merida as its West Coast Operating Partner responsible for overseeing Merida’s portfolio of consumer products companies. Bartlett most recently founded Garden Society, a boutique Sonoma County-based cannabis operator. He previously managed global logistics and supply chain for Costco’s Kirkland Wine & Spirits, along with and several multi-nationally distributed Napa, Sonoma and California premium and luxury wine brands. Matt also established the Wine Division for Bank of Marin (NASDAQ: BMRC); was Vice President at American AgCredit, a part of the National Farm Credit System; and was a Vice President and Regional Manager in Capital Markets Finance for HSBC.

David Lubotta, Partner

David Lubotta has joined Merida as a Partner and will oversee Merida’s Canadian efforts from its new Toronto office. David brings 25 years of Canadian institutional finance experience to Merida, including participation in numerous financings and M&A transactions in cannabis companies such as: Green Therapeutics, Nutritional High, Green Rush, Emerald Family Farms, and Xanthic Biopharma Inc., which was recently purchased by Green Growth Brands.  David holds an MBA from Northwestern Kellogg School of Management.

 


StaffMay 16, 2018
daily_hit004-1280x533.png

6min1810

It’s time for your daily hit of cannabis financial news for May 16, 2018:

On The Site

NY Cannabis Taxes

On May 15, 2018, New York City Comptroller Scott Stringer published a report estimating the potential size of the state’s legal cannabis market and how much tax revenue it would generate for both the city and the state. According to the report, the New York state cannabis market could see up to $3.1 billion in annual sales, with up to $1.1 billion being generated in New York City alone. In terms of tax revenue, legal cannabis could generate up to $436 million for New York state and $336 for New York City.

MariMed Inc.

The U.S.-based medical marijuana company MariMed Inc. (MRMD) stock jumped 13% after it reported its first-quarter financial results for 2018 with revenues increasing 81% to $2.08 million compared to $1.15 million first quarter of 2017.  The company attributed the increase to the expanding operations of MariMed’s medical marijuana clients from real estate revenue, management fees and licensing fees.

Unfortunately, the company delivered a net loss of $1.83 million in the quarter versus net income of $0.11 million for the quarter last year.  MariMed said that the loss was blamed on non-cash equity compensation and debt settlements in 2018 that it said would have no impact on operations/cash flow. MariMed happily reported $251,166 of operating income in first quarter of 2018, an increase from $228,552 for the same time period in 2017.

GrowGeneration Corp.

Denver-based hydroponic retailer GrowGeneration (GRWG) reported that its revenue for the first quarter of 2018 increased 70% to $4.4 million versus $2.6 million for the 1st quarter of 2017. Gross profits rose 75% to approximately $1.2 million compared to approximately $.68 million for the same time period. Still, the company delivered a net loss of $953,430 versus last year’s net loss of $283,309. The stock fell over 7% to $4.70 on the earnings announcement.

After a rocky start at the beginning of the year, the North American Marijuana Index is starting to show some signs of a recovery. In the month of April, the North American Index gained 3%, led primarily by the huge gains in the U.S. market. The U.S. Marijuana Index gained approximately 19% in April; six companies on the index gained 20% or more and another ten companies gained more than 10%. The average trading volume on the U.S. Index also increased by 77%, compared to the previous month.

In Other News

Merida Capital Partners 

Merida Capital Partners a private equity fund targeting fundamental growth drivers underpinning the rapid development of the cannabis industry announced it has crossed $50MM in assets under management (AUM) and closed transactions in nine companies in its second Fund. With the full deployment of Merida’s first tranche of Fund II and the opening of the firm’s second investment tranche, Merida Fund II will continue its focus on high-conviction investments in leading companies that have crossed the ‘fragmentation gap’ yet need strategic capital to profoundly accelerate their respective growth curves. Merida will also focus on businesses implementing capex-lite models in the traditionally capital-intensive verticals of cultivation, dispensing, and life sciences.

Invictus MD Strategies Corp.

Invictus MD Strategies Corp. announced that it has entered into a binding letter of intent for an option to acquire 100% of the outstanding shares of an applicant under the Access to Cannabis for Medical Purposes Regulations from OptionCo current shareholders. OptionCo has two properties. One is located in Delta, British Columbia (“Delta Facility”) and is a state of the art, pharmaceutical grade, cannabis production and research facility, which has been submitted to Health Canada for final review and approval under the ACMPR. The Company expects to receive its cultivation license for the Delta Facility in Q2 of 2018.  The other property is located in Mission, British Columbia


William SumnerFebruary 13, 2018
Kush2.jpg

3min1730

Cannabis packaging company Kush Bottles today announced that the company has entered into a strategic partnership with Merida Capital, a private equity fund targeting the cannabis industry. Kush has received a $6 million equity investment from Merida, which the company will use to expand its product portfolio, build new distribution channels and penetrate new legalized markets.

The announcement comes in the wake of the company reporting a 285% rise in revenue for the first fiscal quarter of 2018, with a net income of $94,615 compared to the previous year’s loss of $161,000.

The strategic partnership will leverage Merida’s strong East Coast presence to help build Kush Bottles’ distribution platform and expand the company’s footprint in East Cost medicinal and recreational market; offering the opportunity for the company to develop and execute its acquisition pipeline with Merida’s help.

In a statement Nicholas Kovacevich, the Chairman and CEO of Kush Bottles said that Merida’s understanding of the unique dynamics of the cannabis industry, as well as its strong networks and willingness to finance Kush Bottles’ growth, would serve as an invaluable asset as the company moves to explore new markets and opportunities.

“We plan to use this capital investment to expand our range of proprietary products to meet the needs of the industry, advance our M&A strategy to take advantage of consolidation in the industry and grow market share,” Kovacevich said.

Echoing Kovacevich’s words, Merida’s Managing Partner, Mitchell Baruchowitz, expressed admiration for the team behind Kush Bottles and their work.

“Since we first started discussing a partnership and investment in Kush Bottles nearly seven months ago, we have been deeply impressed by the vision of Nick and his team and the progress they have made strategically positioning Kush Bottles as much more than simply a packaging company. Kush Bottles’ acquisitions and in-house development efforts have established the Company as a critical link in the supply chain for more than 5,000 cannabis growers, extractors, manufacturers, and retailers. The Merida team could not be more excited to put significant resources to work to build on this foundation to expand Kush Bottles’ leading position,” added Baruchowitz.


Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Back to Top

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.